Medibank director David Koczkar granted additional performance rights

David Koczkar, a director at Medibank Private Limited, was granted an additional 724,646 performance rights on December 12, 2025. These new rights comprise 132,180 performance rights under the FY25 deferred short term incentive (STI) and 592,466 performance rights under the FY26 long term incentive (LTI). These grants were made at nil consideration under the terms of the company's performance rights plan.

Following this transaction, Koczkar's total direct holdings of performance rights increased to 2,275,601. This includes existing performance rights from FY24 and FY25, alongside the newly acquired FY25 and FY26 rights. The company also confirmed that Koczkar's indirect interest in ordinary shares, held via Olive Man Investments Pty Ltd, remains unchanged at 2,420,503 ordinary shares.

The change in Koczkar's interest was authorized for release by Mei Ramsay, company secretary, and the company confirmed no trading occurred during a closed period requiring prior written clearance. This announcement provides transparency regarding director remuneration and shareholdings, in accordance with ASX listing rules.